BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8622877)

  • 1. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
    Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
    Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
    Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
    Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
    Li H; Zhang N
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.
    Yun K; Fukumoto M; Jinno Y
    Am J Pathol; 1996 Apr; 148(4):1081-7. PubMed ID: 8644850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The imprinting status and expression of insulin-like growth factor 2 gene in human hepatocellular carcinoma].
    He WZ; Qin Y; Li B; Liu JY; Sun ZL; Sun ZF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):466-9. PubMed ID: 15291100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M; Seeger RC; Mizoguchi H; Koeffler HP
    Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma.
    Wu J; Qin Y; Li B; He WZ; Sun ZL
    Genomics; 2008 May; 91(5):443-50. PubMed ID: 18358696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
    Wu HK; Weksberg R; Minden MD; Squire JA
    Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
    Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P
    Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver.
    Aihara T; Noguchi S; Miyoshi Y; Nakano H; Sasaki Y; Nakamura Y; Monden M; Imaoka S
    Hepatology; 1998 Jul; 28(1):86-9. PubMed ID: 9657100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of the maternally imprinted IGF2 allele in TGFalpha induced hepatocellular carcinomas in mice.
    Harris TM; Rogler LE; Rogler CE
    Oncogene; 1998 Jan; 16(2):203-9. PubMed ID: 9464538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
    Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
    Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
    Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.